Abiomed Profit Margin

Abiomed (ABMD) currently reports a profit margin of 24.84% as of September 2022. That compares with 15.32% in the prior-year period — up 62.1% year over year. That is above the Healthcare sector average of 15.58%. Use the charts on this page to explore Abiomed's profit margin history and peer comparisons.

Abiomed's profit margin increased from 15.32% to 24.84% — a 62.1% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Abiomed's profit margin of 24.84% is higher than the Healthcare sector average of 15.58%. That is roughly 59.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Abiomed's current 24.84% should be judged against Healthcare norms (sector average: 15.58%) and against ABMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 24.84%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Abiomed, and consider following ABMD for alerts when major investors trade the stock.